Researcher Profile Statistics: Leong Sai Mun
Geo Map
Region
#
AS - Asia, other
7
NA - North America
2
AF - Africa
1
EU - Europe
1
Unknown
4
Total
15
Country
#
SG - Singapore
5
AE - United Arab Emirates
1
CA - Canada
1
GB - United Kingdom
1
HK - Hong Kong
1
NG - Nigeria
1
US - United States of America
1
Unknown
4
Total
15
City
#
London
2
Singapore
2
Abu Dhabi
1
Awka
1
Central
1
Manhattan
1
Unknown
7
Total
15
Bitstream
Downloads
ID: 1481206 - αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells A mechanism mediated by galectin-3.pdf - ITEM:( 10635/237783)
15
Total: {0}
15
Most bitstream per type viewed
#
ID: other -
0
ID: journal -
15
ID: conference -
0
ID: patent -
0
ID: allItems -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
15
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2023
0 0
1 0 1 0
0 1 0 3
1 4
11
2024
2 1
0 1 0 0
0 0 0 0
0 0
4
Ever
15
Geo Map
| Region | # |
|---|---|
| AS - Asia, other | 7 |
| NA - North America | 2 |
| AF - Africa | 1 |
| EU - Europe | 1 |
| Unknown | 4 |
| Total | 15 |
| Country | # |
|---|---|
| SG - Singapore | 5 |
| AE - United Arab Emirates | 1 |
| CA - Canada | 1 |
| GB - United Kingdom | 1 |
| HK - Hong Kong | 1 |
| NG - Nigeria | 1 |
| US - United States of America | 1 |
| Unknown | 4 |
| Total | 15 |
| City | # |
|---|---|
| London | 2 |
| Singapore | 2 |
| Abu Dhabi | 1 |
| Awka | 1 |
| Central | 1 |
| Manhattan | 1 |
| Unknown | 7 |
| Total | 15 |
| Bitstream | Downloads |
|---|---|
| ID: 1481206 - αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells A mechanism mediated by galectin-3.pdf - ITEM:( 10635/237783) | 15 |
| Total: {0} | 15 |
| Most bitstream per type viewed | # |
|---|---|
| ID: other - | 0 |
| ID: journal - | 15 |
| ID: conference - | 0 |
| ID: patent - | 0 |
| ID: allItems - | 0 |
| ID: book - | 0 |
| ID: dataset - | 0 |
| ID: selected - | 0 |
| Total | 15 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 3 | 1 | 4 | 11 |
| 2024 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Ever | 15 | ||||||||||||